P H Warne - JoVE Visualize

Showing results (1-10 of 20) with videos related to

Pageof 2

Sort By:

Oncogene|March 2, 2011

PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugsB Weigelt, P H Warne, J Downward

Oncogene|October 5, 1995

Downregulation of the Ras activation pathway by MAP kinase phosphorylation of SosL Buday, P H Warne, J Downward

Oncogene|December 1, 1994

Role of Shc in the activation of Ras in response to epidermal growth factor and nerve growth factorT Basu, P H Warne, J Downward

Nature|July 22, 1993

Direct interaction of Ras and the amino-terminal region of Raf-1 in vitroP H Warne, P R Viciana, J Downward

Oncogene|June 20, 1996

Networks of interaction of p120cbl and p130cas with Crk and Grb2 adaptor proteinsA Khwaja, B Hallberg, P H Warne, et al.

Clinical & Experimental Metastasis|July 1, 1983

Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part I. Biology of tumour regression and recurrenceD F Tucker, R A Knight, P H Warne

Clinical & Experimental Metastasis|July 1, 1983

Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part II. Sequential analysis of serum immune complexes and blocking activity in reconstituted mice in relation to tumour biologyD F Tucker, R A Knight, P H Warne

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 29, 1996

Phosphatidylinositol 3' kinase: one of the effectors of RasP Rodriguez-Viciana, B M Marte, P H Warne, et al.

Oncogene|November 26, 2009

Rictor is a novel target of p70 S6 kinase-1C Treins, P H Warne, M A Magnuson, et al.

The EMBO Journal|May 15, 1997

Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathwayA Khwaja, P Rodriguez-Viciana, S Wennström, et al.

Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:

Pageof 2

Oncogene|March 2, 2011

PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugsB Weigelt, P H Warne, J Downward

Oncogene|October 5, 1995

Downregulation of the Ras activation pathway by MAP kinase phosphorylation of SosL Buday, P H Warne, J Downward

Oncogene|December 1, 1994

Role of Shc in the activation of Ras in response to epidermal growth factor and nerve growth factorT Basu, P H Warne, J Downward

Nature|July 22, 1993

Direct interaction of Ras and the amino-terminal region of Raf-1 in vitroP H Warne, P R Viciana, J Downward

Oncogene|June 20, 1996

Networks of interaction of p120cbl and p130cas with Crk and Grb2 adaptor proteinsA Khwaja, B Hallberg, P H Warne, et al.

Clinical & Experimental Metastasis|July 1, 1983

Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part I. Biology of tumour regression and recurrenceD F Tucker, R A Knight, P H Warne

Clinical & Experimental Metastasis|July 1, 1983

Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part II. Sequential analysis of serum immune complexes and blocking activity in reconstituted mice in relation to tumour biologyD F Tucker, R A Knight, P H Warne

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 29, 1996

Phosphatidylinositol 3' kinase: one of the effectors of RasP Rodriguez-Viciana, B M Marte, P H Warne, et al.

Oncogene|November 26, 2009

Rictor is a novel target of p70 S6 kinase-1C Treins, P H Warne, M A Magnuson, et al.

The EMBO Journal|May 15, 1997

Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathwayA Khwaja, P Rodriguez-Viciana, S Wennström, et al.

Pageof 2